New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2013
06:11 EDTGERNGeron volatility up into imetelstat induces clinical remissions in some patients
Geron overall option implied volatility of 196 is above its 26-week average of 110 according to Track Data, suggesting large price movement into Imetelstat, Geron's novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a Mayo Clinic study has found.
News For GERN From The Last 14 Days
Check below for free stories on GERN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for GERN

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use